Nanosecond-laser application in intermediate AMD: 12-month results of fundus appearance and macular function.

BACKGROUND A novel, ultra-low energy nanosecond laser (retinal rejuvenation therapy) has been developed with the aim to slow progression of early age-related macular degeneration (AMD). The safety, changes in fundus characteristics and macular function in a cohort of participants with bilateral intermediate AMD are reported. DESIGN Prospective non… (More)